MRSO

MRSO EBITDA per Employee

The EBITDA per Employee of MRSO (5619.T) as of Oct 22, 2026 is -1.71 M JPY. In the previous year, EBITDA per Employee was 8.11 M JPY — a change of -121.05% (lower).

EBITDA per Employee

-1.71 MJPY

YoY

-121.05%

Last updated:

EBITDA per Employee of MRSO is 2025 -1.71 M JPY. EBITDA per Employee of MRSO was 2024 8.11 M JPY. It decreases by -121.05% lower compared to the previous year.

The MRSO EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2021
44.36 M JPY
Jan 1, 2022
49.98 M JPY
Jan 1, 2023
31.18 M JPY
Jan 1, 2024
8.11 M JPY
Jan 1, 2025
-1.71 M JPY
The MRSO EBITDA per Employee history
YEAREBITDA per EmployeeYoY
-1.71 MJPY-121.05%
8.11 MJPY-73.99%
31.18 MJPY-37.62%
49.98 MJPY+12.68%
44.36 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MRSO Stock analysis

What does MRSO do? MRSO Inc generates revenue through comprehensive healthcare platform services including HCPF, which operates MRSO.jp for medical checkup reservations. The company offers DX services for medical facilities featuring MRSO-Plus, a cloud-based reservation management system, and DX services for government with solutions like MRSO Jumin Kenshin, MRSO Vaccine, MRSO Form, and MRSO Go Yoyaku. Large-scale vaccination services provide an online reservation system for vaccinations. Medical facilities and government entities are the primary buyers of these services, utilizing MRSO-Plus for operational efficiency and government systems for public health initiatives. MRSO.jp serves as the core platform for medical checkup reservations, while MRSO Vaccine and MRSO Go Yoyaku target specific vaccination needs. The company’s DX services for medical facilities focus on improving marketing activities and operational efficiency through cloud-based solutions. Government clients purchase systems such as MRSO Jumin Kenshin for resident health checkups and MRSO Form for administrative processes, enhancing public health management. Revenue streams are derived from subscription models for MRSO-Plus, MRSO Vaccine, and other platform services. Medical facilities pay for MRSO-Plus to manage reservations and improve patient engagement, while government agencies invest in MRSO Jumin Kenshin and MRSO Form for large-scale health programs. The vaccination reservation system is a key product for both public health campaigns and routine medical services. MRSO is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MRSO stock

EBITDA per Employee of MRSO is -1.71 M JPY in 2025.

EBITDA per Employee of MRSO changed from 8.11 M JPY to -1.71 M JPY, representing a -121.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee MRSO since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's MRSO historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — MRSO

All Key Metrics — MRSO